Ototoxicity monitoring in children treated with platinum chemotherapy.

about

Cisplatin is retained in the cochlea indefinitely following chemotherapy.Using tablet-based technology to deliver time-efficient ototoxicity monitoring.Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review

P2860

Q46002451-A1790875-E9DF-4956-AFBD-35CE0E544993 Q47688495-3EC32B54-B5D3-432F-B937-7144A3FA292C Q57492125-18468987-ACB0-445C-94E9-B71A73C23D74

P2860

Ototoxicity monitoring in children treated with platinum chemotherapy.

Item

http://www.wikidata.org/entity/Q39453840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ototoxicity monitoring in children treated with platinum chemotherapy.

@en

Ototoxicity monitoring in children treated with platinum chemotherapy.

@nl

type

Item

label

Ototoxicity monitoring in children treated with platinum chemotherapy.

@en

Ototoxicity monitoring in children treated with platinum chemotherapy.

@nl

prefLabel

Ototoxicity monitoring in children treated with platinum chemotherapy.

@en

Ototoxicity monitoring in children treated with platinum chemotherapy.

@nl

P1476

Ototoxicity monitoring in children treated with platinum chemotherapy.

@en

P2093

Beth Brooks

http://www.w3.org/2001/XMLSchema#string

Kristin Knight

http://www.w3.org/2001/XMLSchema#string

P2860

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Platinum-induced hearing loss after treatment for childhood cancer

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer

Auditory development in early amplified children: factors influencing auditory-based communication outcomes in children with hearing loss.

Carboplatin-associated ototoxicity in children with retinoblastoma.

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.

Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma

Mechanisms of cisplatin-induced ototoxicity and prevention.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14992027.2017.1355570

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28737048

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

Ototoxicity monitoring in children treated with platinum chemotherapy.

about

P2860

P2860

Ototoxicity monitoring in children treated with platinum chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921